Skip to main content
Have a personal or library account? Click to login
Zinc and Gold Complexes in the Treatment of Breast Cancer / Kompleksi Cinka I Zlata U Lecenju Karcinoma Dojke Cover

Zinc and Gold Complexes in the Treatment of Breast Cancer / Kompleksi Cinka I Zlata U Lecenju Karcinoma Dojke

EABR. Experimental and Applied Biomedical Research
Volume 17 (2016): Issue 1 (March 2016)
By: ,  ,  ,  ,  ,   and    
Open Access
|Apr 2016
References

References

  1. 1. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell. 100; 57-70.
    Open DOISearch in Google Scholar
  2. 2. Sotiriou C, Pusztai L. (2009). Gene-expression signatures in breast cancer. N Engl J Med. 360; 790-800.
    Open DOISearch in Google Scholar
  3. 3. Acharya A, Das I, Chandhok D, Saha T. (2010). Redox regulation in cancer: A double-edged sword with therapeutic potential. Oxid Med Cell Longev. 3; 23-34.
    Open DOISearch in Google Scholar
  4. 4. Milner JA. (2004). Molecular targets for bioactive food components. J Nutr. 134; 2492S-2498S.
    Search in Google Scholar
  5. 5. Fenech M, Ferguson LR. (2001). Vitamins/minerals and genomic stability in humans. Mut Res. 475; 1-6.
    Open DOISearch in Google Scholar
  6. 6. Ivetic M, Velicki R, Popovic M, Cemerlic-Adjic N, Babovic SS, Velicki L. (2010). Dietary influence on breast cancer. Journal of BUON. 15(3); 455-461.
    Search in Google Scholar
  7. 7. Siewit CL, Gengler B, Vegas E, Puckett R, Louie MC. (2010). Cadmium promotes breast cancer cell proliferation by potentiating the interaction between Er_ and c-Jun. Molecular Mol Endocrinol. 24(5); 981-992.
    Open DOISearch in Google Scholar
  8. 8. Gallagher CM, Chen JJ, Kovach JS. (2010). Enviromental cadmium and breast cancer risk. Aging. 2(11); 804-814.
    Open DOISearch in Google Scholar
  9. 9. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA. (2006). Cadmium exposure and breast cancer risk. J Natl Cancer Inst. 98(12); 896-873.
    Open DOISearch in Google Scholar
  10. 10. Sandstead HH. (1994). Understanding zinc: recent observations and interpretations. J Lab Clin Med. 124(3); 322-327.
    Search in Google Scholar
  11. 11. Heyneman CA. (1996). Zinc deficiency and taste disorders. Ann Pharmacother. 30(2); 186-187.
    Search in Google Scholar
  12. 12. HoE, Ames BN. (2002). Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci U S A. 99(26); 16770-1675.
    Open DOISearch in Google Scholar
  13. 13. Fuwa K, Wacker WE, Druyan R, Bartholomay AF, Vallee BL. (1960). Nucleic Acids and Metals II: Transition Metals as Determinants of the Conformation of Ribonucleic Acids. Proc Natl Acad Sci USA. 46; 1298-1307.
    Open DOISearch in Google Scholar
  14. 14. Paski SC, Xu Z. (2001). Labile intracellular zinc is associated with 3T3 cell growth. J Nutr Biochem. 12; 655-661.
    Open DOISearch in Google Scholar
  15. 15. Andreini C, Banci L, Bertini I, Rosato A. (2006). Counting the zinc-proteins encoded in the human genome. J Proteome Res. 5; 196-201.
    Open DOISearch in Google Scholar
  16. 16. Sekler I, Sensi SL, Hershfinkel M, Silverman WF. (2007). Mechanism and regulation of cellular zinc transport. Mol Med. 13; 337-343.
    Open DOISearch in Google Scholar
  17. 17. Gaither LA, Eide DJ. (2001). Eukaryotic zinc transporters and their regulation. Biometals. 14; 251-270.
    Search in Google Scholar
  18. 18. McClelland RA, Manning DL, Gee JM, Wishler P, Robertson JF, Ellis IO, Blamey RW, Nicholson RI. (1998). Oestrogen-regulated gene sin breast cancer: Association of pLIV1 with response to endocrine therapy. Br _ Cancer. 77; 1653-1656.
    Open DOISearch in Google Scholar
  19. 19. Vašák M, Hasler DW. (2000). Metallothioneins: new functional and structural insights. Curr Opin Chem Biol. 4(2); 177-183.
    Search in Google Scholar
  20. 20. Andreini C, Banci L, Bertini I, Rosato A. (2006). Counting the zinc-proteins encoded in the human genome. J Proteome Res. 5(1); 196-201.
    Open DOISearch in Google Scholar
  21. 21. Liuzzi JP, Cousins RJ. (2004). Mammalian zinc transporters. Annu Rev Nutr. 24; 151-172.
    Search in Google Scholar
  22. 22. DeWys W, Pories W. (1972). Inhibition of spectrum of animal tumors by dietary zinc deficiency. J Natl Cancer Inst. 48(2); 375-381.
    Search in Google Scholar
  23. 23. McQuitty JT Jr, DeWys WD, Monaco L, Strain WH, Rob CG, Apgar J, Pories WJ. (1970). Inhibition of tumor growth by dietary zinc deficiency. Cancer Res. 30(5); 1387-1390.
    Search in Google Scholar
  24. 24. Chakravarty PK, GhoshA, Chowdhury JR. (1976). Zinc in human malignances. Neoplasma. 33(1); 85-90.
    Search in Google Scholar
  25. 25. Mulay IL, Roy R, Knox BE, Suhr NH, Delaney WE. (1971). Trace-metal analysis of cancerous and non cancerous human tissues. J Natl Cancer Inst. 47(1); 1-13.
    Search in Google Scholar
  26. 26. Chasapis CT, Luotsidou AC, Spiliopoulou, Stefanidou ME. (2013). Zinc and human health: an update. Arch Toxicol. 86(4); 521-534.
    Search in Google Scholar
  27. 27. Margalioth EJ, Schenker JG, Chevion M. 1983. Cooper and zinc levels in normal and malignant tissues. Cancer. 52(5); 866-872.
    Open DOISearch in Google Scholar
  28. 28. Alam S, Kelleher SL. (2012). Cellular mechanisms of zinc dysregulation: _ perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer. Nutritiens. 4(8); 875-903.
    Open DOISearch in Google Scholar
  29. 29. El-Tanani MK, Green CD. (1995). Oestrogen-induced genes, pLIV-1 and pS2, respond divergently to other steroid hormones in MCF-7 cells. Mol Cell Endocrinol. 111(1); 75-81.
    Open DOISearch in Google Scholar
  30. 30. Taylor KM, Morgan HE, Johnson A, Hadley LJ, Nicholson RI. (2003); Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters. Biochem J. 375(Pt1); 51-59.
    Open DOISearch in Google Scholar
  31. 31. Kagara N, Tanaka N, Noguchi S, Hirano T. (2007). Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells. Cancer Sci. 98(5); 692-697.
    Open DOISearch in Google Scholar
  32. 32. Zhao L, Chen W, _aylor KM, Cai B, Li X. (2007). LIV-1 suppression inhibits HeLa cell invasion by targeting ERK/2-Snail/Slug pathway. Biochem Biophys Res Commun. 363(1); 82-88.
    Open DOISearch in Google Scholar
  33. 33. Kelleher SL, Seo YA, Lopez V. (2009). Mammary gland zinc metabolism: regulation and dysregulation. Genes Nutr. 4(2); 83-94.
    Open DOISearch in Google Scholar
  34. 34. Lichten LA, Cousins RJ. (2009). Mammalian zinc transporters: nutritional and physiologic regulation. Annu rev nutr. 29; 153-176.
    Search in Google Scholar
  35. 35. McClelland RA, Manning DL, Gee JM, Willsher P, Robertson JF, Ellis IO, Blamey RW, Nicholson RI. (1998). Oestrogen-regulated genes in breast cancer: _ssociation of pLIV1 with response to endocrine therapy. Br J Cancer. 77(10); 1653-1656.
    Open DOISearch in Google Scholar
  36. 36. Manning DL, McClelland RA, Gee JM, Chan Cm, Green CD, Blamey RW, Nicholson RI. (1993). The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer. Eur J Cancer. 29A(10); 1462-1468.
    Open DOISearch in Google Scholar
  37. 37. Taylor KM, Nicholson RI. (2003). The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim Biophysic Acta. 1611(1-2); 16-30.
    Search in Google Scholar
  38. 38. Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2(3); 161-174.
    Open DOISearch in Google Scholar
  39. 39. Lopez V, Foolad F, Kelleher SL. (2011). ZnT2-overexpression represses the cytotoxic effects of zinc hyperaccumulation in malignant metallothionein-null T47D breast tumor cells. Cancer Lett. 304(1); 41-51.
    Open DOISearch in Google Scholar
  40. 40. Truong-Tran AQ, Ho LH, Chai F, Zalewski PD. (2000). Cellular zinc fluxes and the regulation of apoptosis/genedirected cell death. J Nutr. 130(5S Suppl); 1459-1466.
    Open DOISearch in Google Scholar
  41. 41. Seo YA, Lopez V, Kelleher SL. (2011). A histidine-rich motif mediates mitochondrial localization of ZnT2 to modulate mitochondrial function. Am J Physiol Cell Physiol. 300(6); 1479-1489.
    Open DOISearch in Google Scholar
  42. 42. Prasad AS, Beck FW, Endre L, Handschu W, Kukuruga M, Kumar G. (1996). Zinc deficiency affects cell cycle and deoxythymidine kinase gene expression in HUT-78 cells. J Lab Clin Med. 128(1); 51-60.
    Open DOISearch in Google Scholar
  43. 43. Paski SC, Xu Z. (2002). Growth factor stimulated cell proliferation is accompanied by an elevated labile intracellular pool of zinc in 3T3 cells. Can J Physiol Pharmacol. 80(8); 790-795.
    Open DOISearch in Google Scholar
  44. 44. Franklin RB, Costello LC. (2009). The important role of the apoptotic effects of zinc in the development of cancers. J Cell Biochem. 106(5); 750-757.
    Search in Google Scholar
  45. 45. Provinciali M, Di Stefano G, Fabris N. (1995). Dosedependent opposite effect of zinc on apoptosis in mouse thymocytes. Int J Immunopharmacol. 17(9); 735-744.
    Open DOISearch in Google Scholar
  46. 46. Djekovic A, Petrovic B, Bugarcic ZD, Puchta R, van Eldik R. (2012). Kinetics and mechanism of the reactions of Au(III) complexes with some biologically relevant molecules. Dalton Trans. 41(13); 3633-3641.
    Open DOISearch in Google Scholar
  47. 47. Wang Y, He QY, Sun RW, Che CM, Chiu JF. (2005). GoldIII porphyrin 1a induced apoptosis by mitochondrial death pathways related to reactive oxygen species. Cancer Res. 65(24); 11553-11564.
    Open DOISearch in Google Scholar
  48. 48. Lum CT, Liu X, Sun RW, Li XP, Peng Y, He ML, Kung HF, Che CM, Lin MC. (2010). Gold(III) porphyrin 1a inhibited nasopharyngeal carcinoma metastasis in vivo and inhibited cell migration and invasion in vitro. Cancer Lett. 294(2); 159-166.
    Open DOISearch in Google Scholar
  49. 49. Jacques A, Lebrun C, Casini A, Kieffer I, Proux O, Latour JM, Sénèque O. (2015). Reactivity of Cys4 zinc finger domains with gold(III) complexes: insights into the formation of „gold fingers“. Inorg Chem. 54(8); 4104-4113.
    Open DOISearch in Google Scholar
  50. 50. Arsenijevic N. (2012). Biological Effects of Gold(III) Complexes Tested in Vitro and in Vivo. In: Kretsinger RH, Uversky VN & Permiyakov EA. Encyclopedia of Metalloproteins ( pp. 933-935). New York, Heidelberg, Dordrecht, London:Springer.
    Search in Google Scholar
  51. 51. Jain S, Coulter JA, Hounsell AR, Butterworth KT, Mc- Mahon SJ, Hyland WB, Muir MF, Dickson GR, Prise KM, Currell FJ, O’Sullivan JM, Hirst DG. (2011). Cell- Specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radial Oncol Biol Phys. 79(2); 531-539.
    Open DOISearch in Google Scholar
  52. 52. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L. (2004). Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 11(3); 169-183.
    Open DOISearch in Google Scholar
  53. 53. Huschka R, Zuloaga J, Knight MW, Brown LV, Nordlander P, Halas NJ. (2011). Light-induced release of DNA from gold nanoparticles: nanoshells and nanorods. J Am Chem. Soc. 133(31); 12247-12255.
    Open DOISearch in Google Scholar
  54. 54. Gibson JD, Khanal BP, Zubarev ER. (2007). Paclitaxelfunctionalized gold nanoparticles. J Am Chem Soc. 129(37); 11653-11661.
    Open DOISearch in Google Scholar
  55. 55. Liu H, Chen D, Li L, Liu T, Tan L, Wu X, Tang F. (2011). Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew Chem Int Ed Engl. 50(4); 891-895.
    Search in Google Scholar
  56. 56. You J, Zhang R, Zhang G, Zhong M, Liu Y, Van Pelt CS, Liang D, Wei W, Sood AK, Li C. (2012). Photothermalchemotherapy with doxorubicin-loaded hollow gold nanospheres: _ platform for near-infrared light-trigged drug release. J Control Release. 158(2); 319-328.
    Open DOISearch in Google Scholar
  57. 57. Lee J, Chatterjee DK, Lee MH, Krishnan S. (2014). Gold nanoparticles in breast cancer treatment: promise and potential pitfalls. Cancer Lett. 347(1); 46-53.
    Open DOISearch in Google Scholar
  58. 58. Stuchinskaya T, Moreno M, Cook MJ, Edwards DR, Russell DA. (2011). Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyaninegold nanoparticle conjugates. Photochem Photobiol Sci. 10(5); 822-831.
    Open DOISearch in Google Scholar
  59. 59. Xu C, Wang B, Sun S. (2009). Dumbbell-like Au-Fe3O4 nanoparticles for target-specific platin delivery. J Am Chem Soc. 131(12); 4216-4217.
    Open DOISearch in Google Scholar
  60. 60. Joshi P, Chakraborti S, Ramirez-Vick JE, Ansari ZA, Shanker V, Chakrabarti P, Singh SP. (2012). The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells. Colloid Surf B Biointerfaces. 95; 195-200.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/sjecr-2015-0044 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English
Page range: 55 - 60
Submitted on: Jul 22, 2015
Accepted on: Jul 22, 2015
Published on: Apr 14, 2016
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Zinc,
gold complexes,
breast cancer,
anticancer therapy
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2016 Sasa Benazic, Zana Besser Silconi, Jelena Milovanovic, Aleksandar Arsenijevic, Bojana Stojanovic, Marija Milovanovic, Tatjana Kanjevac, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 17 (2016): Issue 1 (March 2016)
Previous article
Next article